Jade completed Pharm.D. training at University at Buffalo School of Pharmacy and Pharmaceutical Sciences (SoPPS). Prior to enrolling in the Pharm.D. program, Jade was a post-graduate researcher at the University of California Davis Cancer Center, and she also worked as a research associate with Cell Biosciences, a start-up company located in Palo Alto, California. While working in the Balthasar Lab, Jade evaluated the use of site-directed mutagenesis to alter the binding affinity of anti-topotecan monoclonal antibodies.